MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 1281-1290 Newer>
The Motley Fool
March 12, 2004
Seth Jayson
Petco Fetches Nice Numbers The No. 2 pet emporium tracks in another year of growth. mark for My Articles 181 similar articles
The Motley Fool
March 12, 2004
Dave Marino-Nachison
The Read on Borders International sales and signs of life at Waldenbooks are helping profit growth. mark for My Articles 245 similar articles
The Motley Fool
March 12, 2004
Rick Aristotle Munarriz
Gateway's Gamble Gateway and eMachines consummate a marriage. Will it work out? mark for My Articles 146 similar articles
The Motley Fool
March 12, 2004
Dave Marino-Nachison
Aeropostale Wings It Buybacks and stock splits may attract investors, but this retailer is also delivering results. mark for My Articles 260 similar articles
The Motley Fool
March 12, 2004
Rick Aristotle Munarriz
Chubby Checkers Staying tried and true to burgers, Checkers earns some serious dough. mark for My Articles 163 similar articles
The Motley Fool
March 12, 2004
Matt Richey
An Earnings Mirage The value investing equivalent of judging a book by its cover is judging a company by its trailing-12-month results. This is the perfect way to overpay for a business whose future isn't nearly so bright as its past. mark for My Articles 10 similar articles
BusinessWeek
March 22, 2004
Gene G. Marcial
Children's Place: Peppy A growing share of the $29 billion market for kids' apparel is luring investors to Children's Place Retail Stores mark for My Articles 7 similar articles
BusinessWeek
March 22, 2004
Gene G. Marcial
Look Who May Be Courting Bioenvision Genzyme may be interested in Bioenvision as well. Why? In 2001, Bioenvision licensed to ILEX the right to co-develop and market in the U.S. and Canada its Clorfarabine, a drug for leukemia. Bioenvision still holds the rights outside North America. The company will soon file for Food & Drug Administration approval of Clorfarabine, which has a $1 billion market potential. mark for My Articles 65 similar articles
BusinessWeek
March 22, 2004
Gene G. Marcial
Landec: Keeping Produce And Skin Lotion Fresher Its patented technology, Intelimer polymer, is used in packaging with breathable membranes to give produce extended shelf life. Landec has licensed the Dole brand for its packaging. mark for My Articles 18 similar articles
The Motley Fool
March 11, 2004
W.D. Crotty
More Vail Promises Will a company synonymous with U.S. skiing ever catch any air? mark for My Articles 94 similar articles
<Older 1281-1290 Newer>    Return to current articles.